Guaifenex PPA 75 Interactions
There are 192 drugs known to interact with Guaifenex PPA 75 (guaifenesin / phenylpropanolamine), along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 46 are major, 143 are moderate, and 3 are minor.
- View all 192 medications that may interact with Guaifenex PPA 75
- View Guaifenex PPA 75 alcohol/food interactions (1)
- View Guaifenex PPA 75 disease interactions (5)
Most frequently checked interactions
View interaction reports for Guaifenex PPA 75 (guaifenesin / phenylpropanolamine) and the medicines listed below.
- alprazolam
- amlodipine
- atorvastatin
- calcium / vitamin d
- carvedilol
- Chelated Magnesium (magnesium amino acids chelate)
- citicoline
- clonidine
- clopidogrel
- dextroamphetamine
- echinacea
- elderberry
- furosemide
- gabapentin
- levothyroxine
- lisinopril
- Livalo (pitavastatin)
- loratadine
- lorazepam
- magnesium oxide
- Norvasc (amlodipine)
- omeprazole
- phentermine
- Premarin (conjugated estrogens)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Tenormin (atenolol)
- timolol ophthalmic
- Viberzi (eluxadoline)
- Viibryd (vilazodone)
- Vitamin B12 (cyanocobalamin)
Guaifenex PPA 75 alcohol/food interactions
There is 1 alcohol/food interaction with Guaifenex PPA 75 (guaifenesin / phenylpropanolamine).
Guaifenex PPA 75 disease interactions
There are 5 disease interactions with Guaifenex PPA 75 (guaifenesin / phenylpropanolamine) which include:
Report options
More about Guaifenex PPA 75 (guaifenesin / phenylpropanolamine)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
